BESTSELLER99.67%
Images are representative. Products are lyophilised research peptides in sterile vials. COA shown above when available for the current batch.
WEIGHT LOSS
Retatrutide
Triple GLP-1/GIP/Glucagon agonist for metabolic and obesity research.
Research Overview
Retatrutide (LY3437943) is a first-in-class triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Preclinical and early clinical research has demonstrated significant effects on body weight, glucose metabolism, and lipid regulation. Each vial is lyophilised under nitrogen, HPLC-verified at ≥99.2% purity, and ships with a full Certificate of Analysis from our GMP-certified manufacturer.
Select Dosage
Select Quantity
Custom Qty
1
COD
Cash on Delivery
COA
Viewable online
1–2d
Discreet delivery
24h
Dispatch
2K+
Orders
99.2%
Purity
5
mg/ml
0.05
ml/dose
5
units (U-100)
40
doses/vial
For research calculation only. Not dosing guidance. U-100 = 100 units per ml.
Store lyophilised vials refrigerated (2–8°C), protected from light. Once reconstituted, keep refrigerated and use within the period appropriate to the compound. Shipped in insulated, temperature-controlled packaging.
This product is strictly for laboratory and analytical purposes. Not for human or veterinary use. By ordering, you confirm you are a qualified researcher operating in compliance with applicable regulations.